The global paracetamol IV market size was USD 797.08 million in 2024, estimated at USD 823.78 million in 2025, and is expected to reach around USD 1,117.85 million by 2034, expanding at a CAGR of 3.4% ...
Post-Operative Use of Intravenous Paracetamol Reduces Use of Morphine in Infants Who Undergo Surgery
A new study reveals that the postoperative use of intermittent intravenous paracetamol in managing pain among infants who undergo major surgery led to a lower cumulative morphine dose over 48 hours A ...
Introduction: There are recent observations on the haemodynamics of intravenous paracetamol (hypotension) in adult IC setting (1). We therefore evaluated the haemodynamics following iv paracetamol ...
VRL had filed the post-grant opposition against SCR Pharmatop’s intravenous paracetamol patent back in 2011 before Indian Patent Office on several grounds such as lack of novelty and inventive steps, ...
Hospitals spanning England face critically low levels of intravenous paracetamol - as a national shortage of the popular painkiller runs on. Paracetamol administered via an IV is the safest and most ...
In a decision dated 4 th June, 2021, the Indian Patent Office decided in favour of Venus Remedies and upheld its decision for revocation of the Indian patent on the grounds that the process lacked any ...
New Delhi, Jun 17 () Drug firm Venus Remedies on Thursday said it has won a 10-year-long patent battle against French firm SCR Pharmatop with regards to production of the intravenous paracetamol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results